An Indian pharmaceutical company is gearing up to sell a cheap version of the leading patented antiviral flu drug Tamiflu to emerging economies, in a move that will pitch intellectual property rights against affordable access to medicines.

Cipla, based in Mumbai, said on Wednesday it had agreed to sell significant quantities of its Antiflu preparation to Mexico, the country at the centre of the current flu outbreak.